EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
EUPRAXIA PHARMACEUTICALS INC.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 13, 2026
$6.95+0.33 (+4.98%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
$0FY2025